Category: ASC News

Physician sues Sutter Health for alleged retaliation

A former hospice physician has alleged wrongful termination and retaliation against San Francisco-based Sutter Visiting Nurse Association and Hospice Sutter Care at Home, the Northern California Record reported Jan. 23. 

4 hospitals shuttering services in 2025

Becker’s reported on four hospitals or health systems shuttering services since Jan. 1, which could shift how ASCs in these markets operate. 

Who is at risk when Medicare gets cut?

Republican lawmakers have outlined significant Medicare cuts, which include implementing site-neutral payments, eliminating funding for hospital bad debts and reducing uncompensated care funding. Hospitals’ access to special Medicare payment classifica…

The Stark law, kickback threats in ASC transactions 

ASCs must navigate a complex regulatory landscape to mitigate risks during ownership transactions, particularly for multispecialty ASCs. 

3 physicians suing their former employer

Here are cases of physicians suing their former employers since Jan. 1, 2025, as reported by Becker’s:

Pain physician, practice to pay $3.5M to settle fraud allegations

A pain management physician and his medical practice will pay $3.5 million, among other penalties, to resolve allegations of billing for medically unnecessary testing and pre-signing opioid prescriptions.

Indiana Senate advances physician noncompete ban

The Indiana state Senate advanced a bill that would ban noncompete agreements for physicians in the state, WNIN reported Jan. 22. 

LA wildfire ASC closures: 5 updates

Wildfires in the Los Angeles area have continued to rage on since Jan. 7, with thousands of people displaced, thousands of structures destroyed and many left homeless. 

Inflation and ASCs in 5 numbers

Here are five numbers on inflation and how its impacting ASCs in 2025:

3 highest-paid physician specialties: 8 comparisons to know

Orthopedic surgeons, plastic surgeons and cardiologists were named the three highest-paid physician specialists in 2024, according to Medscape.